Immutep Limited (ASX: IMM; NASDAQ: IMMP) 29 April 2020: ASX and NASDAQ listed biotechnology company Immutep Limited (“Immutep“ or the “Company“), is pleased to announce that it has today successfully completed a A$12 million placement (Placement) to professional, institutional and sophisticated investors.
For more information, download the attached PDF.
Download this document
